ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
OncoSec Announces FDA Clearance for Trial of COVID-19 Vaccine Candidate americanpharmaceuticalreview
November 09, 2020OncoSec Medical announced the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for a first-in-human Phase 1 trial for CORVax12, a novel DNA-encodable vaccine against SARS-CoV-2 that the Company ...
Pharma Sources Insight January 2025
